Accuracy of a continuous glucose monitoring system
Part of Hormones & metabolism clinical trials.
This trial tests a new continuous glucose monitor that checks blood sugar levels without frequent finger pricks. It aims to see how accurate and safe it is for people with type 1 diabetes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have type 1 diabetes.
- You can have a blood sample taken from your forearm.
- You can read and follow instructions, and you sign the consent form.
- You have not had severe low blood sugar in the past 6 months.
- You do not have conditions like heart failure, skin problems at the sensor site, blood disorders, or are not pregnant or planning pregnancy.
- You do not plan to have MRI or CT scans during the sensor wear.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
This study looks at how people with diabetes feel about using a continuous glucose monitor (CGM) and their blood sugar readings. It aims to learn what works best for patients and healthcare providers to improve diabetes care.
This trial tests a new device that measures blood sugar and ketones continuously. It may help people with type 1 diabetes who use an insulin pump keep better track of their levels.
This trial tests a new continuous glucose monitor (a small sensor that checks blood sugar levels) to see how well and safely it works in people with type 1 diabetes. You'll wear the sensor for 15 days and attend three clinic visits to check its accuracy against blood samples.
This study tests two continuous glucose monitors (CGMs) worn on the arm to see how accurate and safe they are. A CGM is a small device that checks your blood sugar levels without finger pricks. The trial lasts about 17 days and involves wearing two sensors at the same time.
This study tests a new continuous glucose monitor (CGM) that you wear for 14 days. It checks how accurate the device is and how well it helps track your blood sugar levels, all while being safe and easy to use.
Hear when a new Type1diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.